# PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ppar-agonist-attenuates-renal-interstitial-fibrosis-and-inflammation-through/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tōru Kawai,Takao Masaki,Shigehiro Doi,Tetsuji Arakawa,Yukio Yokoyama,Toshiki Doi,Nobuoki Kohno,Noriaki Yorioka |
| Citations | 203 |
| DOI | 10.1038/labinvest.2008.104 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nature.com/articles/labinvest2008104.pdf |
| OpenAlex ID | https://openalex.org/W1484016032 |
| PMID | 19002105 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Shigehiro Doi](https://scholariq.org/researchers/shigehiro-doi/)
- [Takao Masaki](https://scholariq.org/researchers/takao-masaki/)

## Paper journal

- [Laboratory Investigation](https://scholariq.org/journals/laboratory-investigation/)

## Paper primary topic

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)

## Paper topics

- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.